Page 200 - AACN Essentials of Critical-Care Nursing Pocket Handbook, Second Edition

Proarrhythmic effects; moderate negative inotropy; dizziness; conduction abnormalities Therapeutic range: 0.2-1 mg/L Proarrhythmic effects; negative inotropy; dizziness; nausea; conduction abnormalities Proarrhythmic effects; dizziness;

Comments 187

Dosage
100-200 mg PO q12h 150-300 mg PO q8h 100-300 mg PO q8h

Antiarrhythmic Agents (continued) Indications Life-threatening ventricular arrhythmias refractory to other agents Prevention of symptomatic, disabling, paroxysmal supraventricular arrhythmias, including atrial fibrillation or flutter and WPW in pati

Agents Class IC Flecainide Propafenone Class IB/IC (hybrid electrophysiologic effects) Moricizine
7.4